MicrobiologyNature CommunicationsPeer-reviewed
Oral drug repositioning candidates and synergistic remdesivir combinations for the prophylaxis and treatment of COVID-19
M. A. Bakowski, N. Beutler, E. Chen…·T. F. Rogers
The paper identifies 66 compounds that inhibit SARS-CoV-2 replication and 24 that synergize with remdesivir, suggesting potential oral drug repositioning candidates for COVID-19.
DOI 10.1038/s41467-021-23328-0